News & Events

Philogen to attend the ESMO TAT congress in Paris on February 26-28, 2024

Dec 18, 2023

Prof. Dr. Giuseppe Curigliano, on behalf of Philogen, is giving a presentation about the Phase I DODEKA study on February 26th, entitled “Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors”.

Dr. Jacqueline Mock is presenting a poster about Philochem’s new small molecule drug conjugate on February 26th, entitled “Optimisation of FAP-targeted small molecule drug conjugates for the delivery and release of cytotoxic payloads in solid tumors”

Follow the link for more details.